Historical record - last NADAC effective date: 1/1/2024
Product Information
IMITREX 50 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $73.0682 per EA under NDC 00173073601. Its NADAC has been published 580 times since Nov 28, 2013.
FDA first approved this application on Jun 1, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173073601
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2024
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020132FDA Approved
6/1/1995
TE Code
AB
On Market Since
12/17/2003
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 50 MG TABLET has been published 580 times since Nov 28, 2013, and over the history we have for it it has risen 125.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.0682 per EA |
|---|---|
| All-time high | $73.0682 (Jan 15, 2025) |
| All-time low | $32.4106 (Nov 28, 2013) |
| Median price | $63.0292 |
| Average price | $59.7453 |
| Largest weekly change | +15.0% (Jan 14, 2015) |
| Weeks tracked | 580 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.0%
5Y
+9.3%
All
+125.4%
Last surveyed Jan 15, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMITREX 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 50 MG TABLET, manufactured by GlaxoSmithKline LLC, is $73.0682 per EA (NDC 00173073601), effective Jan 15, 2025.
How has the price of IMITREX 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMITREX 50 MG TABLET has risen 125.4%. It has been tracked across 580 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 50 MG TABLET?
Since Nov 28, 2013, the NADAC for IMITREX 50 MG TABLET has ranged from a low of $32.4106 (Nov 28, 2013) to a high of $73.0682 (Jan 15, 2025), with a median of $63.0292 per EA.
Are there cheaper alternatives to IMITREX 50 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN SUCC 50 MG TABLET, is $0.2994 per EA — about 99% below IMITREX 50 MG TABLET.
Who manufactures IMITREX 50 MG TABLET?
IMITREX 50 MG TABLET (NDC 00173073601) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.